Clinical trial
CA-125 in Screening Patients at High Risk for Ovarian Cancer
NCT00080639 · University of Alabama at Birmingham, Other · Withdrawn
Key facts
| NCT number | NCT00080639 |
|---|---|
| Title | CA-125 in Screening Patients at High Risk for Ovarian Cancer |
| Official title | Specialized Program Of Research Excellence (SPORE) In Ovarian Cancer/Cancer Genetics Network Collaborative Ovarian Cancer Screening Pilot Trial In High Risk Women |
| Lead sponsor | University of Alabama at Birmingham, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Withdrawn |
| Study type | Observational |
| Conditions | Ovarian Cancer |
| Intervention type | Other, Procedure |
| Interventions | physiologic testing, study of high risk factors |
| Enrollment | 0 |
| Start date | Jun 1, 2003 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Apr 8, 2004 |
| Last update posted | Aug 5, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: